A ƙarshen shekarun 1990s, likitoci na farko na kwayar cutar sun tafi kasuwa don magance cututtuka na rheumatoid . Enbrel (akidar) shine na farko, amma bai yi tsawo ba don sauran kwayoyin halittu don bunkasa da kasuwa.
Bisa ga UpToDate ( amintacciyar hanyar lantarki mai amfani da likitoci da marasa lafiya suke amfani da su a cikin zurfin bayani da kuma bayanin likita):
"Abubuwan da suka dace da kwayoyin halitta, waɗanda aka fi sani da kwayoyin halittu, sune magunguna waɗanda aka tsara don hana ko rage ƙananan da ke lalata kayan aiki. zai iya haifar da kumburi da haɗuwa tare da juna. Akwai nau'o'in kwayoyin halittu masu yawa, kowanne ɗayan yana ƙaddamar da wani nau'i na kwayoyin da ke cikin wannan tsari (ƙananan kwayoyin necrosis, interleukin-1, da kuma kwayoyin halitta a jikin T-B lymphocytes T da B). "
Magungunan ilimin halitta da manufofin su
- Enbrel (akida), Remicade (infliximab), Humira (adalimumab), Simponi (golimumab), da Cimzia (certolizumab pegol) sune kwayoyi masu ilimin kwayoyin halitta da suke ci gaba da ƙwayoyin ƙwayoyin necrosis na tumbu (TNF). An kira su masu mahimmanci TNF kuma, yawanci, daya daga cikin masu tayar da hankulan TNF ita ce ta farko da aka gwada magunguna.
- Kineret (anakinra) ya hana interleukin-1. Ana ganin shi a matsayin wani ilimin kwayar halitta mai mahimmanci fiye da masu tarin fuka na TNF kuma ba a tsara su ba.
- Orencia (abatacept) yana katse kunna tarin T. Yawancin lokaci, Orencia an adana marasa lafiya da cututtuka masu tsauri zuwa matsananciyar cututtuka wanda ba su iya magance cutar tare da hanya da kuma mai tsaro TNF.
- Rituxan (rituximab) ya rushe sassan B. Bugu da ƙari, wannan miyagun ƙwayoyi yana yawanci adana marasa lafiya wanda ke da sakamako mara kyau da methotrexate kuma mai tsaro na TNF.
- Actemra (tocilizumab) yayi aiki ta hanyar hana mai karɓa na interleukin-6, don haka ya hana interleukin-6.
Wa ya kamata a bi da shi tare da ilimin halitta?
Magunguna da suka sami amsa ga DMARDs (cututtukan maganin cutar antirheumatic), ko dai shi kadai ko a hade tare da wasu magungunan maganin arthritis, yawanci masu kirki ne na ilimin halitta. Idan aka kwatanta da DMARDs, ilimin halittu yayi aiki da sauri. Ya kamata ku san ko kuna amsawa a cikin makonni na farawa da miyagun kwayoyi.
Wanene Ba'a Yin Biyuwa da Lafiya?
Abin takaici, akwai marasa lafiya wadanda basu da 'yan takara masu kyau don magance kwayoyin halitta. Akwai wasu sharuɗɗa inda kasada zasu fi ƙarfin amfani da maganin kwayoyi.
Alal misali, marasa lafiya da tarihin farko na sclerosis ko lymphoma ba zasu zama masu kirki ba ne. Marasa lafiya da cututtukan zuciya sun kasance marasa kirki. Har ila yau mawuyacin amfani da kwayoyin halitta lokacin da mai haƙuri yana da tarihin cututtuka mai tsanani ko ci gaba.
Wanne daga cikin ilimin Halitta Ya Kamata Ka Yi Amfani?
Kwararka zai taimaka maka ka zabi mafi kyawun halittu donka. Kudin kuɗi ne sosai. Dole da likitanka dole su ƙayyade idan asusun kiwon lafiya naka zai rufe kwayar da ka zaɓa-ko abin da kuɗin kuɗin kuɗi zai kasance.
Tabbatar cewa yana da araha gare ku.
Wani ra'ayi shine saukakawa. Yaya ake amfani da miyagun ƙwayoyi? Shin dole ne ku je ofishin likita domin magani ko zai fi kyau a gareku ku zabi daya daga cikin kwayoyin kwayoyin da ake gudanarwa a matsayin mai kai kanka? Sau nawa ne ake amfani da miyagun ƙwayoyi-sau ɗaya a mako, sau biyu a mako, kowane mako biyu, ko kowane wata? Me kuke so?
Har ila yau, yana da mahimmanci a gare ka ka zabi wani miyagun ƙwayoyi wanda ke da rikodi mai kyau, a wasu kalmomi, daya daga cikin tsofaffi, maimakon sababbin sababbin halittu? Dukkanin waɗannan abubuwa ne don la'akari saboda idan ka zabi abin da ya fi dacewa da kai, za ka iya kasancewa mai dacewa tare da maganinka.
Source:
Maini RN da Venables PJW. "Bayanin haƙuri: Rheumatoid arthritis magani" UpToDate.